Market Introduction
Tissue processing is used to prepare the tissue for microscopic analysis by putting the tissue in a tangible medium. Tissue processing helps provide skinny and high-quality slices mounted on the glass slides and properly stained to indicate normal and abnormal structures. Tissue processing systems are widely used in cancer diagnostic laboratories, where biopsy samples are processed for cancer diagnosis.
Market Overview and Dynamics
The North America tissue processing systems market is expected to reach US$ 252.56 million by 2027 from US$ 167.72 million in 2019; it is estimated to grow at a CAGR of 5.4% from 2020 to 2027. The market growth is mainly attributed to the rising prevalence of cancer and increasing number of diagnostic laboratories in North America. However, the high cost of cancer diagnostics restricts the market growth.
Key Market Segments
The North America tissue processing systems market, based on product, is segmented into tissue transfer processors and fluid transfer processors. The fluid transfer processors segment held the largest share of the market in 2019, and the tissue transfer processors segment is expected to register the highest CAGR in the market during the forecast period.
The North America tissue processing systems market, by volume, is segmented into small volume processors, medium volume processors, and large volume processors. The small volume processors segment held the largest share of the market in 2019, and the medium volume processors segment is anticipated to register the highest CAGR in the market during the forecast period.
On the basis of end user, the North America tissue processing systems market is segmented into hospitals, pharmaceutical companies, research laboratories, and others. The hospitals segment held the largest share of the market in 2019, and the pharmaceutical companies segment is estimated to register the highest CAGR in the market during the forecast period.
Major Sources and Companies Listed
A few of the primary and secondary sources associated with this report on the North America tissue processing systems market are the World Health Organization (WHO), Centers for Medicare & Medicaid Services (CMS), and National Cancer Institute (NCI).
Reasons to buy the report
NORTH AMERICA TISSUE PROCESSING SYSTEMS SEGMENTATION
By Volume
By Country
Company Profiles
| Report Attribute | Details |
|---|---|
| Market size in 2019 | US$ 167.72 Million |
| Market Size by 2027 | US$ 252.56 Million |
| CAGR (2020 - 2027) | 5.4% |
| Historical Data | 2017-2018 |
| Forecast period | 2020-2027 |
| Segments Covered |
By Product
|
| Regions and Countries Covered |
North America
|
| Market leaders and key company profiles |
|
The North America Tissue Processing Systems Market is valued at US$ 167.72 Million in 2019, it is projected to reach US$ 252.56 Million by 2027.
As per our report North America Tissue Processing Systems Market, the market size is valued at US$ 167.72 Million in 2019, projecting it to reach US$ 252.56 Million by 2027. This translates to a CAGR of approximately 5.4% during the forecast period.
The North America Tissue Processing Systems Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Tissue Processing Systems Market report:
The North America Tissue Processing Systems Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The North America Tissue Processing Systems Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the North America Tissue Processing Systems Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)